#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metabolic disorder Mastocytosis Asthma Pulmonary tuberculosis Paraganglion neoplasm Chronic cutaneous lupus erythematosus Antiphospholipid antibodies Propionic acidaemia Angiosarcoma Mucopolysaccharidosis III Leiomyosarcoma recurrent Primary biliary cholangitis Transitional cell cancer of the renal pelvis and ureter Chronic graft versus host disease in liver Acute hepatic failure More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Diagnostics Mastocytosis – Basic Information Sarcoidosis – Diagnostics Hereditary hypophosphataemic rickets – Basic Information Rhabdomyosarcoma – Treatment Ewing’s sarcoma recurrent – Diagnostics Bronchiolitis obliterans syndrome – Diagnostics Urea cycle disorder – Basic Information Castleman’s disease – Life with Disease Haemophilia B with anti factor IX – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Ph. Eur. Naproxen Sodium Deoxyribonucleic Acid Betula Pollen Extract Heparin Calcium Magnesium Oxybate Eftrenonacog Alfa Gadoteridol Sar441566 Netupitant Risperidone Neflamapimod Immunoglobulin G LY4170156 Opelconazole Isis 678354 Sodium Salt Omp12 Fexofenadine Hydrochloride Cobamamide Aaa802 More therapies…

    Learn about Your Condition

    Colon cancer stage III Haemorrhage intracranial Constipation Aplasia pure red cell Postoperative wound infection Limb reduction defect Renal cancer stage IV Hepato-lenticular degeneration Arteriospasm coronary Oesophagectomy Meningioma malignant Marginal zone lymphoma Alagille syndrome Aortic stenosis COVID-19 More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    • Obesity
    • Overweight
    Investigated Drugs:
    • Medroxyprogesterone Acetate
    • Dydrogesterone
    • Glucose
    Germany

  • Study on the Effects of Liraglutide on Hunger and Digestion in Obese Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Liraglutide
    • Saline
    Belgium

  • Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    • Obesity
    • Overweight
    Investigated Drugs:
    • Semaglutide
    • Sodium Chloride
    Denmark

  • Study of semaglutide treatment for adolescents with obesity caused by antipsychotic medications

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on the Effectiveness and Safety of Orforglipron for Weight Management in Adolescents with Obesity or Overweight

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Italy Poland
Previous Page
1 2 3 4 5 6 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!